Clinical trial
Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases…
NCT00143403 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143403 |
|---|---|
| Title | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer |
| Official title | Multi-Centre Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone, As Adjuvant Treatment After Resection Of Liver Metastases For Colorectal Cancer. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Liver Neoplasms |
| Intervention type | Drug |
| Interventions | Irinotecan + 5 FU + folinic acid, Folinic Acid + 5 FU |
| Enrollment | 321 |
| Start date | Dec 1, 2001 |
| Primary completion | Feb 1, 2008 |
| Completion | Sep 1, 2009 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 28, 2010 |
| Countries | Belgium, Denmark, France, Germany, Hong Kong, Israel, Italy, Portugal, South Africa, South Korea, Spain, Sweden and 4 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: